Literature DB >> 33507253

Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement Among Patients With Dementia.

Dae Hyun Kim1,2,3, Xihao Li4, Shijia Bian5, Lee-Jen Wei4, Ryan Sun6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33507253      PMCID： PMC7844593          DOI： 10.1001/jamanetworkopen.2020.34745

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  6 in total

1.  Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.

Authors:  Robert Howard; Rupert McShane; James Lindesay; Craig Ritchie; Ashley Baldwin; Robert Barber; Alistair Burns; Tom Dening; David Findlay; Clive Holmes; Robert Jones; Roy Jones; Ian McKeith; Ajay Macharouthu; John O'Brien; Bart Sheehan; Edmund Juszczak; Cornelius Katona; Robert Hills; Martin Knapp; Clive Ballard; Richard G Brown; Sube Banerjee; Jessica Adams; Tony Johnson; Peter Bentham; Patrick P J Phillips
Journal:  Lancet Neurol       Date:  2015-10-27       Impact factor: 44.182

2.  Donepezil and memantine for moderate-to-severe Alzheimer's disease.

Authors:  Robert Howard; Rupert McShane; James Lindesay; Craig Ritchie; Ashley Baldwin; Robert Barber; Alistair Burns; Tom Dening; David Findlay; Clive Holmes; Alan Hughes; Robin Jacoby; Rob Jones; Roy Jones; Ian McKeith; Ajay Macharouthu; John O'Brien; Peter Passmore; Bart Sheehan; Edmund Juszczak; Cornelius Katona; Robert Hills; Martin Knapp; Clive Ballard; Richard Brown; Sube Banerjee; Caroline Onions; Mary Griffin; Jessica Adams; Richard Gray; Tony Johnson; Peter Bentham; Patrick Phillips
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

3.  Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results.

Authors:  Dae Hyun Kim; Hajime Uno; Lee-Jen Wei
Journal:  JAMA Cardiol       Date:  2017-11-01       Impact factor: 14.676

4.  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

Authors:  Patricia Guyot; A E Ades; Mario J N M Ouwens; Nicky J Welton
Journal:  BMC Med Res Methodol       Date:  2012-02-01       Impact factor: 4.615

5.  Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time.

Authors:  Zachary R McCaw; Ariela R Orkaby; Lee-Jen Wei; Dae Hyun Kim; Michael W Rich
Journal:  Am J Med       Date:  2018-08-01       Impact factor: 5.928

6.  Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  BMC Med Res Methodol       Date:  2013-12-07       Impact factor: 4.615
  6 in total
  1 in total

1.  Error in the Discussion Section.

Authors: 
Journal:  JAMA Netw Open       Date:  2021-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.